X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (109) 109
oncology (91) 91
female (85) 85
male (85) 85
middle aged (85) 85
aged (72) 72
surgery (72) 72
adult (62) 62
index medicus (56) 56
rectal neoplasms - pathology (46) 46
neoplasm staging (44) 44
rectal neoplasms - surgery (43) 43
aged, 80 and over (38) 38
retrospective studies (37) 37
cancer (34) 34
chemotherapy (34) 34
combined modality therapy (32) 32
treatment outcome (32) 32
rectal neoplasms - therapy (31) 31
carcinoma (30) 30
prognosis (28) 28
radiotherapy (28) 28
rectal cancer (27) 27
survival (24) 24
colorectal-cancer (23) 23
follow-up studies (23) 23
rectal neoplasms - mortality (23) 23
medicine & public health (22) 22
care and treatment (21) 21
survival rate (20) 20
total mesorectal excision (20) 20
chemoradiation (19) 19
colorectal cancer (19) 19
neoadjuvant therapy (19) 19
article (18) 18
rectal neoplasms - radiotherapy (18) 18
surgical oncology (18) 18
therapy (18) 18
analysis (16) 16
chemoradiotherapy (16) 16
disease-free survival (16) 16
radiation-therapy (16) 16
rectal neoplasms - drug therapy (16) 16
adenocarcinoma (15) 15
adenocarcinoma - pathology (15) 15
fluorouracil (15) 15
gastroenterology & hepatology (15) 15
survival analysis (15) 15
abridged index medicus (14) 14
adenocarcinoma - surgery (14) 14
rectal-cancer (14) 14
young adult (14) 14
adenocarcinoma - therapy (13) 13
neoplasm recurrence, local - pathology (13) 13
radiology, nuclear medicine & medical imaging (13) 13
radiotherapy dosage (13) 13
rectum (13) 13
resection (13) 13
time factors (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
chemotherapy, adjuvant (12) 12
neoplasm recurrence, local (12) 12
recurrence (12) 12
adjuvant chemotherapy (11) 11
colonic neoplasms - pathology (11) 11
preoperative radiotherapy (11) 11
radiotherapy, adjuvant (11) 11
risk factors (11) 11
trial (11) 11
adjuvant therapy (10) 10
colon-cancer (10) 10
fluorouracil - administration & dosage (10) 10
lymphatic metastasis (10) 10
multivariate analysis (10) 10
neoplasm recurrence, local - surgery (10) 10
patients (10) 10
pelvic exenteration (10) 10
preoperative care (10) 10
radiation therapy (10) 10
adenocarcinoma - mortality (9) 9
age factors (9) 9
hematology, oncology and palliative medicine (9) 9
local excision (9) 9
local recurrence (9) 9
management (9) 9
oxaliplatin (9) 9
postoperative complications (9) 9
prospective studies (9) 9
quality-of-life (9) 9
risk (9) 9
5-fluorouracil (8) 8
adolescent (8) 8
colectomy (8) 8
colon (8) 8
morbidity (8) 8
neoplasm recurrence, local - mortality (8) 8
neoplasm recurrence, local - therapy (8) 8
quality of life (8) 8
radiation (8) 8
radiology and nuclear medicine (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 15, pp. 1770 - 1776
Journal Article
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 3/2013, Volume 21, Issue 3, pp. 793 - 802
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 07/2014, Volume 12, Issue 7, pp. 1028 - 1059
The NCCN Guidelines for Colon Cancer address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance,... 
PHASE-III TRIAL | GROWTH-FACTOR RECEPTOR | UNRESECTABLE LIVER METASTASES | BEVACIZUMAB-CONTAINING ARMS | ONCOLOGY | HIGH-DOSE LEUCOVORIN | POSTPROGRESSION SURVIVAL-TIME | 1ST-LINE COMBINATION CHEMOTHERAPY | KRAS WILD-TYPE | CAPECITABINE PLUS OXALIPLATIN | METASTATIC COLORECTAL-CANCER | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Colonic Neoplasms - drug therapy | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Bevacizumab | Colonic Neoplasms - surgery | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - therapeutic use | Deoxycytidine - adverse effects | Leucovorin - therapeutic use | Cetuximab | Liver Neoplasms - secondary | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Camptothecin - therapeutic use | Fluorouracil - analogs & derivatives | Membrane Proteins - genetics | Liver Neoplasms - drug therapy | Liver Neoplasms - surgery | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | GTP Phosphohydrolases - genetics | Proto-Oncogene Proteins B-raf - genetics | Colonic Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 3, pp. 824 - 830
Purpose We designed this Phase II trial to assess the efficacy and safety of the addition of bevacizumab to concurrent neoadjuvant capecitabine-based... 
Radiology | Hematology, Oncology and Palliative Medicine | Neoadjuvant | Rectal cancer | Chemoradiation | Bevacizumab | SURGERY | LEUCOVORIN | OXALIPLATIN | CHEMOTHERAPY | RADIATION-THERAPY | ONCOLOGY | PREOPERATIVE RADIOTHERAPY | INFUSIONAL 5-FLUOROURACIL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Follow-Up Studies | Capecitabine | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Surgical Wound Dehiscence - chemically induced | Antibodies, Monoclonal, Humanized | Fluorouracil - administration & dosage | Adult | Dose Fractionation | Female | Rectal Neoplasms - pathology | Rectal Neoplasms - drug therapy | Fluorouracil - analogs & derivatives | Rectal Neoplasms - surgery | Deoxycytidine - administration & dosage | Rectal Neoplasms - radiotherapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - adverse effects | Neoadjuvant Therapy - methods | Aged | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Clinical trials | Care and treatment | Angiogenesis inhibitors | Radiotherapy | Cancer | Index Medicus | Acute toxicity | GASTROINTESTINAL TRACT | LARGE INTESTINE | INJURIES | NEOPLASMS | RECTUM | DIGESTIVE SYSTEM | TOXICITY | INTESTINES | ANTINEOPLASTIC DRUGS | HEALING | MEDICINE | NUCLEAR MEDICINE | BIOLOGICAL RECOVERY | ORGANS | DISEASES | THERAPY | WOUNDS | DRUGS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BODY | RADIOLOGY
Journal Article
Annals of Surgery, ISSN 0003-4932, 12/2019, Volume 270, Issue 6, pp. 937 - 941
OBJECTIVE:To review efficiency metrics and patient safety data before and after implementation of a structured review process for surgical innovations. SUMMARY... 
SURGERY | patient safety | WARM-UP | device implementation | technology transfer | STATE | process improvement | REHEARSAL | ETHICAL-ISSUES
Journal Article